The F.D.A. ended its recommended pause on the J.&J. vaccine, clearing the way for states to use it again.

The F.D.A. ended its recommended pause on the J.&J. vaccine, clearing the way for states to use it again.
A vial containing doses of the Johnson & Johnson Covid-19 vaccine.Credit...Bryan Anselm for The New York Times
April 23, 2021, 5:02 a.m. ET
The Food and Drug Administration ended its recommended pause on the Johnson & Johnson Covid-19 vaccine on Friday and will add a warning to its label to note the potential risk of rare blood clots.
The decision, which clears the way for states to resume vaccinations, came after a panel of advisers to the Centers for Disease Control and Prevention voted to end the pause in a meeting on Friday.

Related Keywords

United States ,Joanne Waldstreicher ,Johnson Covid ,Centers For Disease ,European Union ,Drug Administration ,Johnson ,Disease Control ,Internal Tag To Designate Essential Content ,Blood Clot ,Vaccines Immunization ,Coronavirus Covid 19 ,Product Labels ,Advisory Committee On Immunization Practices ,Cdc ,ஒன்றுபட்டது மாநிலங்களில் ,மையங்கள் க்கு நோய் ,ஐரோப்பிய தொழிற்சங்கம் ,ஜான்சன் ,நோய் கட்டுப்பாடு ,இரத்தம் உறைதல் ,தடுப்பு மருந்துகள் நோய்த்தடுப்பு ,ப்ராடக்ட் லேபிள்கள் ,ஸீடீக் ,